📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of an AIM2 inflammasome inhibitor for the treatment of DNA-driven inflammatory disease (2022)

First Author: Green J

Attributed to: New insights into NLRP3 within inflammatory disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.07.28.501942

Publication URI: http://dx.doi.org/10.1101/2022.07.28.501942

Type: Preprint